Molecular therapy for Metastatic cancers: Myrtenal, isolated  from Taxus, increases the expression of DNA repair protein hMSH2 and the tumor suppressor protein CADM1 , inhibits cell cycle progression, and suppresses migration, invasion and metastasis of cancer cells via up regulation of its target gene, 5/September/2017, 11.43 pm

Natural product-derived CDK4/6 pathway blockade enhances the efficacy of Cancer immunotherapy: A pharmacological mixture encompassing Linalool, 17-AAG, Simvastatin, Nimbolide, Deoxycholic acid and Trichostatin A (LASNDT)  inhibits the expression of cell cycle protein CDK4/CDK6, increases levels of T-III IFNs, inhibits the proliferation of Treg cells, decreases DNMT1 expression, inhibits the expression of a number of immune evasion molecules, increases antigen presentation and unfolding response, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target genes, 5/September/2017, 3.37 am
September 4, 2017
Natural product-derived antiviral therapy against Hepatitis-B virus: EGCG (Epigallocatechin gallate), found abundantly in Green tea, increases the expression of Setd2, methylates STAT1, activates STAT1, promotes trimethylation of IFN-stimulated gene-15, and restricts Hepatitis-B virus (HBV) production and pathogenesis via up regulation of its target gene, 05/September/2017,  11.53 am
September 5, 2017
Show all

Teacher’s day special

*********

We wish everyone a happy Teacher’s day. On this special occasion, we are happy to announce that ideas posted today (05/September/2017) will be available to the use of Scientists/Professors/Physicians/Researchers for free.

So, there will be no terms and conditions, for the ideas posted today (05/September/2017). Each idea posted will be served first come, first served basis.Write to info@genomediscovery.org for more details.

Dr L Boominathan PhD

CEO & CSO, GBMD

______________________________________________________________________________________________________________

From Significance of the study to Public health relevance:

Given that: (i) each year nearly 14 million people are diagnosed with cancer globally, and little more than half of them will die; (ii) cancer deaths globally are expected to be doubled by 2030; (iii) most of the cancer patients die due to metastasis; (iv) cancer treatment causes the highest economic loss compared to all the known causes of death worldwide, there is an urgent need to find: (i) bio-molecules that drive metastatic process; and the the way to prevent their expression; (ii) a way to activate immune system to combat cancer (Cancer immunotherapy); (ii) a cheaper alternative to the existing expensive anticancer drugs; (ii) a side-effect-free natural product-based drug; (iii) increase the therapeutic index of anticancer drugs; and (iv) a way to effectively treat and prevent metastatic progression and relapse of advanced/drug-resistant cancers.


Research findings to Therapeutic opportunity: 

A number of studies suggests that Myrtenal inhibits tumor cell proliferation. However, the mechanism of action is far from clear.

This study suggests that Myrtenal, by regulating the expression of its target genes, it may increase the expression of  DNA repair protein hMSH2 and the tumor suppressor protein CADM1 (fig. 1).

Thereby, it may: (a) inhibit cell cycle progression; and (d) suppress migration, invasion and metastasis of cancer cells. 

Thus,  Myrtenal-based treatment may be advised for metastatic cancer patients to (i) increase the expression of metastasis suppressor genes in tumors; (ii) inhibit the progression of metastatic tumors; and (ii) enhance the efficacy of Cancer therapy. Together, oncologists may consider experimenting the use of Myrtenal in the treatment of advanced metastatic cancers.


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Undisclosed mechanistic information: How Myrtenal increases the expression of NA repair protein hMSH2 and the tumor suppressor protein CADM1 

Fig1. Mechanistic insights into how the natural product-derived compound Myrtenal functions as an anti-metastasis agent. Myrtenal increases the expression of DNA repair protein hMSH2 and the tumor suppressor protein CADM1 via down regulation of its target genes.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

For more details, you may reach us at info@genomediscovery.org

# Research cooperation


References: 

CitationBoominathan, L., Molecular therapy for Metastatic cancers: Myrtenal, isolated  from Taxus, increases the expression of DNA repair protein hMSH2 and the tumor suppressor protein CADM1 , inhibits cell cycle progression, and suppresses migration, invasion and metastasis of cancer cells via up regulation of its target gene, 5/September/2017, 11.43 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.